Medicine Description
is a relatively selective alpha-2 adrenergic receptor agonist (topical intraocular pressure lowering agent). INDICATIONS indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. DRUG INTERACTIONS Antihypertensives/Cardiac Glycosides Because ALPHAGAN� P (brimonidine tartrate) may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with ALPHAGAN� P (brimonidine tartrate) is advised. CNS Depressants Although specific drug interaction studies have not been conducted with ALPHAGAN� P (brimonidine tartrate) , the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, sedatives, or anesthetics) should be considered.
|
the price brimonocond 0.2 % Eye Drops in saudi arabia |
26.69 SAR | SAR |
|
the price brimonocond 0.2 % Eye Drops in uae |
26.69 AED | AED |
|
the price brimonocond 0.2 % Eye Drops in kuwait |
2.18 KWD | KWD |
|
the price brimonocond 0.2 % Eye Drops in oman |
2.67 OMR | OMR |
|
the price brimonocond 0.2 % Eye Drops in Bahrain |
2.67 BHD | BHD |